Contraception is an important consideration for many individuals and couples. As technology advances, so does the availability of new methods of contraception. One of the most recent developments is Nexplanon, a long-acting reversible contraceptive (LARC) that is inserted under the skin of the upper arm. This article will explore the benefits of Nexplanon and discuss the implications for the future of contraception.
Nexplanon is a type of LARC, which is a form of contraception that is inserted under the skin of the upper arm and can remain effective for up to three years. It is a small, flexible rod that is inserted just beneath the skin and releases progestin, a hormone that prevents pregnancy. It is a highly effective form of contraception, with a failure rate of less than 1%. Unlike other forms of contraception, such as the pill, Nexplanon does not require daily or weekly maintenance and does not interfere with sexual activity.
Nexplanon offers many benefits to users, including:
The development of Nexplanon has implications for the future of contraception. As a highly effective form of contraception that is easy to use and does not interfere with sexual activity, Nexplanon is likely to become increasingly popular in the future. Furthermore, the development of LARCs such as Nexplanon could lead to the development of other long-acting contraceptives, such as implants and intrauterine devices, which could offer even greater convenience and effectiveness.
Nexplanon is a highly effective form of contraception that offers many benefits to users. It is easy to use, does not interfere with sexual activity, and can remain effective for up to three years. The development of Nexplanon has implications for the future of contraception, as it could lead to the development of other long-acting contraceptives that offer even greater convenience and effectiveness.
1.
More Positive Survival Data in Lung Cancer With Perioperative Therapy
2.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
3.
Study finds 10% of pediatric blood cancers may stem from medical imaging radiation
4.
For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.
5.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
1.
Case Study: Artificial Intelligence in Early Cancer Detection
2.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
3.
What is Mullerian and How Does it Affect Your Health
4.
AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation